These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation. Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Rajkumar SV; Lacy MQ; Kyle RA Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905 [TBL] [Abstract][Full Text] [Related]
9. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience. Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression. Kyle RA; Rajkumar SV Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088 [TBL] [Abstract][Full Text] [Related]
11. Modern treatment of amyloidosis: unresolved questions. Dember LM J Am Soc Nephrol; 2009 Mar; 20(3):469-72. PubMed ID: 19073820 [TBL] [Abstract][Full Text] [Related]
12. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M; Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308 [TBL] [Abstract][Full Text] [Related]
13. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival. Lahuerta JJ; Mateos MV; Martínez-López J; Rosiñol L; Sureda A; de la Rubia J; García-Laraña J; Martínez-Martínez R; Hernández-García MT; Carrera D; Besalduch J; de Arriba F; Ribera JM; Escoda L; Hernández-Ruiz B; García-Frade J; Rivas-González C; Alegre A; Bladé J; San Miguel JF J Clin Oncol; 2008 Dec; 26(35):5775-82. PubMed ID: 19001321 [TBL] [Abstract][Full Text] [Related]
14. [Primary amyloidosis associated with IgD-lambda M-proteinemia]. Kimura S; Iwatsuka R; Aoki T; Odawara J; Asada N; Yamakura M; Takeuchi M; Matsue K Rinsho Ketsueki; 2007 Dec; 48(12):1555-8. PubMed ID: 18203516 [TBL] [Abstract][Full Text] [Related]
15. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment in systemic amyloidosis]. Ikeda S Rinsho Byori; 2008 Feb; 56(2):121-9. PubMed ID: 18404826 [TBL] [Abstract][Full Text] [Related]
19. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation. Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH; Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634 [TBL] [Abstract][Full Text] [Related]
20. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease. Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]